Fresenius Medical Care AG (FMS)
19.45
+0.06
(+0.31%)
USD |
NYSE |
Apr 19, 10:29
Fresenius Medical Care Cash from Financing (TTM): -2.012B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.012B |
| September 30, 2023 | -1.409B |
| June 30, 2023 | -1.410B |
| March 31, 2023 | -1.404B |
| December 31, 2022 | -1.706B |
| September 30, 2022 | -1.934B |
| June 30, 2022 | -1.816B |
| March 31, 2022 | -1.468B |
| December 31, 2021 | -1.212B |
| September 30, 2021 | -1.378B |
| June 30, 2021 | -1.954B |
| March 31, 2021 | -2.830B |
| December 31, 2020 | -3.042B |
| September 30, 2020 | -2.637B |
| June 30, 2020 | -2.317B |
| March 31, 2020 | -1.598B |
| December 31, 2019 | -522.39M |
| September 30, 2019 | -287.45M |
| June 30, 2019 | 382.75M |
| March 31, 2019 | -399.71M |
| December 31, 2018 | -805.00M |
| September 30, 2018 | -1.106B |
| June 30, 2018 | -1.576B |
| March 31, 2018 | -645.37M |
| December 31, 2017 | -904.45M |
| Date | Value |
|---|---|
| September 30, 2017 | -916.53M |
| June 30, 2017 | -795.18M |
| March 31, 2017 | -534.33M |
| December 31, 2016 | -575.20M |
| September 30, 2016 | -691.73M |
| June 30, 2016 | -665.09M |
| March 31, 2016 | -644.69M |
| December 31, 2015 | -1.007B |
| September 30, 2015 | -67.78M |
| June 30, 2015 | 243.71M |
| March 31, 2015 | 517.37M |
| December 31, 2014 | 880.36M |
| September 30, 2014 | 274.14M |
| June 30, 2014 | -2.275M |
| March 31, 2014 | -407.31M |
| December 31, 2013 | -777.15M |
| September 30, 2013 | -943.32M |
| June 30, 2013 | -1.176B |
| March 31, 2013 | -1.061B |
| December 31, 2012 | 455.28M |
| September 30, 2012 | 1.060B |
| June 30, 2012 | 1.219B |
| March 31, 2012 | 1.770B |
| December 31, 2011 | 853.27M |
| September 30, 2011 | 496.42M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.042B
Minimum
Dec 2020
382.75M
Maximum
Jun 2019
-1.608B
Average
-1.598B
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
| DaVita Inc | -1.170B |
| Biodexa Pharmaceuticals Plc | 7.972M |
| NuCana PLC | -0.0659M |
| Biophytis SA | 7.617M |
| TC BioPharm (Holdings) PLC | 10.62M |